Funds holding BioNTech SE
ISIN US09075V1026 · Germany · LEI 894500UZJ5LG1F8J1U58
- Fund holders
- 162
- Of which ETFs
- 30 132 other funds
- Value held
- 2B $ 287.9M SEK · 1.1M €
162 funds hold this company. This table lists the 157 that declare it in a regulatory filing. The other 5 publish their holdings in their own reports. They are not in the table.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Dodge & Cox International Stock Fund Dodge & Cox Funds | 2,517,713 | 223.8M $ | 0.37 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Capital Appreciation Fund T. ROWE PRICE CAPITAL APPRECIATION FUND, INC. | 2,272,437 | 202M $ | 0.31 % | as of Mar 31, 2026 ↗ |
| VANGUARD CAPITAL OPPORTUNITY FUND VANGUARD HORIZON FUNDS | 2,189,120 | 194.6M $ | 0.79 % | as of Mar 31, 2026 ↗ |
| Fidelity Contrafund Fidelity Contrafund | 2,039,853 | 181.3M $ | 0.11 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Mid-Cap Growth Fund, Inc. T. ROWE PRICE MID-CAP GROWTH FUND, INC. | 1,019,300 | 90.6M $ | 0.40 % | as of Mar 31, 2026 ↗ |
| PRIMECAP Odyssey Aggressive Growth Fund PRIMECAP Odyssey Funds | 919,146 | 95.1M $ | 1.40 % | as of Apr 30, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 807,711 | 71.8M $ | 3.16 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 599,506 | 53.3M $ | 0.66 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 570,401 | 62.9M $ | 0.08 % | as of Feb 28, 2026 ↗ |
| Fidelity Emerging Markets Fund Fidelity Investment Trust | 546,500 | 56.5M $ | 0.53 % | as of Apr 30, 2026 ↗ |
| Dodge & Cox Global Stock Fund Dodge & Cox Funds | 525,778 | 46.7M $ | 0.39 % | as of Mar 31, 2026 ↗ |
| MFS Mid Cap Value Fund MFS SERIES TRUST XI | 492,991 | 43.8M $ | 0.27 % | as of Mar 31, 2026 ↗ |
| JNL/T. Rowe Price Capital Appreciation Fund JNL Series Trust | 482,340 | 42.9M $ | 0.31 % | as of Mar 31, 2026 ↗ |
| Fidelity Contrafund K6 Fidelity Contrafund | 444,604 | 39.5M $ | 0.12 % | as of Mar 31, 2026 ↗ |
| PRIMECAP Odyssey Growth Fund PRIMECAP Odyssey Funds | 355,600 | 36.8M $ | 0.68 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Capital Appreciation Equity ETF T. Rowe Price Exchange-Traded Funds, Inc. | 282,533 | 25.1M $ | 0.40 % | as of Mar 31, 2026 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 280,000 | 30.9M $ | 0.50 % | as of Feb 28, 2026 ↗ |
| VY(R) T. ROWE PRICE CAPITAL APPRECIATION PORTFOLIO Voya Investors Trust | 227,361 | 20.2M $ | 0.31 % | as of Mar 31, 2026 ↗ |
| Schwab Fundamental International Equity ETF SCHWAB STRATEGIC TRUST | 211,270 | 23.3M $ | 0.10 % | as of Feb 28, 2026 ↗ |
| Fidelity Value Fund Fidelity Capital Trust | 200,000 | 20.7M $ | 0.21 % | as of Apr 30, 2026 ↗ |
| JNL/T. Rowe Price Mid-Cap Growth Fund JNL Series Trust | 173,400 | 15.4M $ | 0.38 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 170,287 | 18.8M $ | 0.08 % | as of Feb 28, 2026 ↗ |
| SEB Läkemedelsfond SEB Funds AB | 170,060 | 144M SEK | 0.89 % | as of Mar 31, 2026 ↗ |
| Penn Series Flexibly Managed Fund Penn Series Funds Inc | 166,696 | 14.8M $ | 0.32 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 148,302 | 16.3M $ | 0.08 % | as of Feb 28, 2026 ↗ |
| Strategic Advisers Fidelity U.S. Total Stock Fund Fidelity Rutland Square Trust II | 145,000 | 16M $ | 0.01 % | as of Feb 28, 2026 ↗ |
| Strategic Advisers Fidelity Emerging Markets Fund Fidelity Rutland Square Trust II | 141,200 | 15.6M $ | 0.04 % | as of Feb 28, 2026 ↗ |
| Nomura International Core Equity Fund IVY FUNDS | 137,896 | 12.3M $ | 1.01 % | as of Mar 31, 2026 ↗ |
| Select Pharmaceuticals Portfolio Fidelity Select Portfolios | 132,653 | 14.6M $ | 0.96 % | as of Feb 28, 2026 ↗ |
| ARK Genomic Revolution ETF ARK ETF Trust | 126,929 | 13.1M $ | 1.06 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Institutional Mid-Cap Equity Growth Fund T. Rowe Price Equity Funds, Inc. | 124,500 | 11.1M $ | 0.40 % | as of Mar 31, 2026 ↗ |
| Fidelity New Millennium Fund Fidelity Mt. Vernon Street Trust | 121,600 | 13.4M $ | 0.25 % | as of Feb 28, 2026 ↗ |
| Franklin International Growth Fund Franklin Global Trust | 106,400 | 11M $ | 1.73 % | as of Apr 30, 2026 ↗ |
| International Equity Portfolio NORTHWESTERN MUTUAL SERIES FUND INC | 99,000 | 8.8M $ | 0.38 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio Developed World ex-US ETF SPDR INDEX SHARES FUNDS | 96,445 | 8.6M $ | 0.02 % | as of Mar 31, 2026 ↗ |
| MassMutual Mid Cap Growth Fund MASSMUTUAL SELECT FUNDS | 95,800 | 8.5M $ | 0.31 % | as of Mar 31, 2026 ↗ |
| VIP Mid Cap Portfolio Variable Insurance Products Fund III | 94,000 | 8.4M $ | 0.10 % | as of Mar 31, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 90,077 | 8M $ | 2.15 % | as of Mar 31, 2026 ↗ |
| Empower T. Rowe Price Mid Cap Growth Fund EMPOWER FUNDS, INC. | 87,270 | 7.8M $ | 0.41 % | as of Mar 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 85,400 | 9.4M $ | 0.18 % | as of Feb 28, 2026 ↗ |
| Baillie Gifford International Alpha Fund Baillie Gifford Funds | 82,416 | 7.3M $ | 0.39 % | as of Mar 31, 2026 ↗ |
| Fidelity U.S. Equity Central Fund Fidelity Central Investment Portfolios LLC | 80,000 | 7.1M $ | 0.04 % | as of Mar 31, 2026 ↗ |
| Nomura VIP International Core Equity Series Ivy Variable Insurance Portfolios | 76,770 | 6.8M $ | 1.02 % | as of Mar 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 73,400 | 7.6M $ | 0.73 % | as of Apr 30, 2026 ↗ |
| Fidelity Balanced Fund Fidelity Puritan Trust | 72,001 | 7.9M $ | 0.01 % | as of Feb 28, 2026 ↗ |
| JPMorgan BetaBuilders Europe ETF J.P. Morgan Exchange-Traded Fund Trust | 65,915 | 6.8M $ | 0.08 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 60,160 | 6.6M $ | 0.03 % | as of Feb 28, 2026 ↗ |
| JNL/MFS Mid Cap Value Fund JNL Series Trust | 57,426 | 5.1M $ | 0.28 % | as of Mar 31, 2026 ↗ |
| Fidelity Mid Cap Value Fund Fidelity Devonshire Trust | 55,052 | 5.7M $ | 0.27 % | as of Apr 30, 2026 ↗ |
| Baillie Gifford International Stock Portfolio Brighthouse Funds Trust II | 54,018 | 4.8M $ | 0.39 % | as of Mar 31, 2026 ↗ |
| Large-Cap Growth Portfolio PACIFIC SELECT FUND | 50,628 | 4.5M $ | 0.37 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Mid Cap Growth Portfolio Brighthouse Funds Trust I | 47,320 | 4.2M $ | 0.40 % | as of Mar 31, 2026 ↗ |
| Swedbank Robur Healthcare Swedbank Robur Fonder AB | 46,200 | 39.1M SEK | 0.28 % | as of Mar 31, 2026 ↗ |
| Invesco NASDAQ Next Gen 100 ETF Invesco Exchange-Traded Fund Trust II | 45,059 | 5M $ | 0.55 % | as of Feb 28, 2026 ↗ |
| Strategic Advisers Emerging Markets Fund Fidelity Rutland Square Trust II | 42,200 | 4.7M $ | 0.03 % | as of Feb 28, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 41,921 | 4.6M $ | 0.07 % | as of Feb 27, 2026 ↗ |
| JNL/T. Rowe Price Capital Appreciation Equity Fund JNL Series Trust | 41,544 | 3.7M $ | 0.41 % | as of Mar 31, 2026 ↗ |
| Schwab Fundamental International Equity Index Fund SCHWAB CAPITAL TRUST | 41,485 | 4.3M $ | 0.09 % | as of Apr 30, 2026 ↗ |
| Handelsbanken Global Index Criteria Handelsbanken Fonder AB | 36,983 | 30.8M SEK | 0.02 % | as of Mar 31, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 35,000 | 3.1M $ | 0.31 % | as of Mar 31, 2026 ↗ |
| Handelsbanken Europa Index Criteria Handelsbanken Fonder AB | 30,995 | 25.8M SEK | 0.10 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF SPDR SERIES TRUST | 30,681 | 2.7M $ | 0.12 % | as of Mar 31, 2026 ↗ |
| JPMorgan BetaBuilders International Equity ETF J.P. Morgan Exchange-Traded Fund Trust | 29,777 | 3.1M $ | 0.05 % | as of Apr 30, 2026 ↗ |
| First Trust Long/Short Equity ETF First Trust Exchange-Traded Fund III | 28,161 | 2.9M $ | 0.13 % | as of Apr 30, 2026 ↗ |
| Fidelity ZERO International Index Fund Fidelity Concord Street Trust | 28,081 | 2.9M $ | 0.03 % | as of Apr 30, 2026 ↗ |
| Fidelity Blue Chip Value Fund Fidelity Securities Fund | 25,800 | 2.7M $ | 0.42 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 25,322 | 2.8M $ | 0.03 % | as of Feb 28, 2026 ↗ |
| Invesco RAFI Developed Markets ex-U.S. ETF Invesco Exchange-Traded Fund Trust II | 24,731 | 2.6M $ | 0.09 % | as of Apr 30, 2026 ↗ |
| Capital Appreciation Value Fund John Hancock Funds II | 24,542 | 2.7M $ | 0.25 % | as of Feb 28, 2026 ↗ |
| Hartford Global Impact Fund HARTFORD MUTUAL FUNDS, INC | 21,576 | 2.2M $ | 0.66 % | as of Apr 30, 2026 ↗ |
| TIFF MULTI-ASSET FUND TIFF Investment Program | 20,039 | 1.8M $ | 0.13 % | as of Mar 31, 2026 ↗ |
| SEB Europafond SEB Funds AB | 20,000 | 17.1M SEK | 0.60 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Mid Cap II Fund Fidelity Advisor Series I | 19,300 | 1.7M $ | 0.10 % | as of Mar 31, 2026 ↗ |
| Handelsbanken Developed Markets Index Criteria Handelsbanken Fonder AB | 19,194 | 16M SEK | 0.03 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Mid-Cap Growth Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 19,131 | 1.7M $ | 0.40 % | as of Mar 31, 2026 ↗ |
| Multi-Manager International Equity Strategies Fund COLUMBIA FUNDS SERIES TRUST I | 19,047 | 2.1M $ | 0.07 % | as of Feb 28, 2026 ↗ |
| Global X Genomics & Biotechnology ETF GLOBAL X FUNDS | 18,367 | 2M $ | 3.87 % | as of Feb 28, 2026 ↗ |
| MFS Mid Cap Value Portfolio MFS VARIABLE INSURANCE TRUST III | 18,074 | 1.6M $ | 0.27 % | as of Mar 31, 2026 ↗ |
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 18,000 | 1.6M $ | 0.24 % | as of Mar 31, 2026 ↗ |
| Optimum International Fund Optimum Fund Trust | 17,618 | 1.6M $ | 0.15 % | as of Mar 31, 2026 ↗ |
| Capital Appreciation Value Trust John Hancock Variable Insurance Trust | 16,899 | 1.5M $ | 0.32 % | as of Mar 31, 2026 ↗ |
| Biotechnology Fund Rydex Series Funds | 16,159 | 1.4M $ | 1.06 % | as of Mar 31, 2026 ↗ |
| VIP Stock Selector Portfolio Variable Insurance Products Fund | 16,000 | 1.4M $ | 0.03 % | as of Mar 31, 2026 ↗ |
| MML Mid Cap Growth Fund MML SERIES INVESTMENT FUND | 15,337 | 1.4M $ | 0.39 % | as of Mar 31, 2026 ↗ |
| JNL International Index Fund JNL Series Trust | 14,486 | 1.3M $ | 0.04 % | as of Mar 31, 2026 ↗ |
| UBS International Sustainable Equity Fund UBS FUNDS | 13,846 | 1.2M $ | 0.91 % | as of Mar 31, 2026 ↗ |
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 12,800 | 1.4M $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Baillie Gifford International Concentrated Growth Equities Fund Baillie Gifford Funds | 12,683 | 1.1M $ | 1.34 % | as of Mar 31, 2026 ↗ |
| Steward Values Enhanced International Fund Steward Funds Inc | 12,642 | 1.3M $ | 0.43 % | as of Apr 30, 2026 ↗ |
| Fidelity Flex International Index Fund Fidelity Salem Street Trust | 10,432 | 1.1M $ | 0.03 % | as of Apr 30, 2026 ↗ |
| Franklin Mutual Small-Mid Cap Value Fund Franklin Value Investors Trust | 10,130 | 1M $ | 0.47 % | as of Apr 30, 2026 ↗ |
| Virtus Biotech Etf ETFis Series Trust I | 9,981 | 1M $ | 1.74 % | as of Apr 30, 2026 ↗ |
| Small Cap Value Fund Northern Funds | 9,581 | 851.6K $ | 0.14 % | as of Mar 31, 2026 ↗ |
| SEB European Defence & Security Fund SEB Funds AB | 9,349 | 7.9M SEK | 0.51 % | as of Mar 31, 2026 ↗ |
| AVIP Fidelity Institutional AM Equity Growth Portfolio AuguStar Variable Insurance Products Fund Inc | 9,259 | 822.9K $ | 0.38 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Value Fund Fidelity Advisor Series I | 8,391 | 868K $ | 0.23 % | as of Apr 30, 2026 ↗ |
| AXS Green Alpha ETF INVESTMENT MANAGERS SERIES TRUST II | 7,688 | 683.3K $ | 1.58 % | as of Mar 31, 2026 ↗ |
| Nomura Focused International Core ETF Nomura ETF Trust | 7,066 | 628K $ | 1.03 % | as of Mar 31, 2026 ↗ |
| Fidelity SAI Sustainable Sector Fund Fidelity Summer Street Trust | 6,857 | 755.8K $ | 0.11 % | as of Feb 28, 2026 ↗ |
| Guardian Large Cap Fundamental Growth VIP Fund Guardian Variable Products Trust | 6,424 | 571K $ | 0.38 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Global X Genomics & Biotechnology ETF GLOBAL X FUNDS | 3.87 % | as of Feb 28, 2026 ↗ |
| Langar Global Health Tech ETF SPINNAKER ETF SERIES | 3.28 % | as of Mar 31, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 3.16 % | as of Mar 31, 2026 ↗ |
| Echiquier Health Impact for All La Financière de l'Échiquier | 2.55 % | as of Jun 30, 2025 ↗ |
| Echiquier World Equity Growth La Financière de l'Échiquier | 2.23 % | as of Mar 31, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 2.15 % | as of Mar 31, 2026 ↗ |
| EUROPE 30 PROFUND ProFunds | 2.10 % | as of Apr 30, 2026 ↗ |
| WisdomTree BioRevolution Fund WisdomTree Trust | 2.09 % | as of Mar 31, 2026 ↗ |
| PROFUND VP EUROPE 30 ProFunds | 1.93 % | as of Mar 31, 2026 ↗ |
| Franklin Genomic Advancements ETF Franklin Templeton ETF Trust | 1.80 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 141 | +6 | 21,055,737 | +10.9 % |
| 2026Q1 | 135 | -18 | 18,986,471 | -4.0 % |
| 2025Q4 | 153 | -14 | 19,772,784 | +19.0 % |
| 2025Q3 | 167 | +11 | 16,611,285 | +6.6 % |
| 2025Q2 | 156 | -4 | 15,579,722 | +6.1 % |
| 2025Q1 | 160 | +37 | 14,679,590 | +20.3 % |
| 2024Q4 | 123 | +28 | 12,197,517 | +23.4 % |
| 2024Q3 | 95 | +12 | 9,883,719 | -4.6 % |
| 2024Q2 | 83 | 0 | 10,361,530 | +0.2 % |
| 2024Q1 | 83 | -5 | 10,340,942 | +2.0 % |
| 2023Q4 | 88 | 10,136,650 |
Institutional managers
271 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 5,856,073 | 520.5K $ | as of Mar 31, 2026 |
| FMR LLC | 5,709,240 | 507.4M $ | as of Mar 31, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | 3,793,711 | 337.2M $ | as of Mar 31, 2026 |
| FLOSSBACH VON STORCH SE | 3,680,315 | 327.1M $ | as of Mar 31, 2026 |
| Dodge & Cox | 3,676,791 | 326.8M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 1,658,153 | 147.4M $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 1,651,789 | 146.8M $ | as of Mar 31, 2026 |
| Temasek Holdings (Private) Ltd | 1,506,027 | 133.9M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 951,372 | 84.6M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 903,029 | 80.3M $ | as of Mar 31, 2026 |
| GSK plc | 889,824 | 79.1M $ | as of Mar 31, 2026 |
| BAILLIE GIFFORD & CO | 882,572 | 78.4M $ | as of Mar 31, 2026 |
| FIRST TRUST ADVISORS LP | 839,991 | 74.7M $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 783,995 | 69.7M $ | as of Mar 31, 2026 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 670,514 | 59.6M $ | as of Mar 31, 2026 |
| Long Focus Capital Management, LLC | 624,000 | 55.5M $ | as of Mar 31, 2026 |
| Candriam S.C.A. | 488,367 | 43.4M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 482,411 | 42.9M $ | as of Mar 31, 2026 |
| DekaBank Deutsche Girozentrale | 481,397 | 42.1K $ | as of Mar 31, 2026 |
| VICTORY CAPITAL MANAGEMENT INC | 476,923 | 42.4M $ | as of Mar 31, 2026 |
| TANG CAPITAL MANAGEMENT LLC | 470,000 | 41.8M $ | as of Mar 31, 2026 |
| DEUTSCHE BANK AG\ | 391,689 | 34.8M $ | as of Mar 31, 2026 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 387,214 | 34.4M $ | as of Mar 31, 2026 |
| LBP AM SA | 385,109 | 34.2M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 384,626 | 34.2M $ | as of Mar 31, 2026 |
Declared shareholders of BioNTech SE
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| ATHOS KG and 2 others | 40.20 % | 101,702,378 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding BioNTech SE". https://titelia.com/en/stocks/biontech-se-US09075V1026